A phase 3, multicenter study to assess the long-term safety, tolerability and efficacy of alks 3831 in subjects with schizophrenia

Authors
Category Primary study
JournalSchizophrenia Bulletin
Year 2019
This article has no abstract
Epistemonikos ID: 534db8079b726d5fe12fef6d579e7e83b49141b0
First added on: Feb 11, 2025